McClaskey James Paul's Form 4 filing
Bruker Cellular Analysis, Inc. (CELL) · filed Oct 24, 2022
- Accession no.
- 0001567619-22-018732
- Filed
- Oct 24, 2022
- Trade date
- Oct 20, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $242.78. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McClaskey James PaulCIK 0001920558 | Officer (SVP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2022 | Common Stock | SSaleDisposed | −122 | $1.99 | −$242.78 | 67,231 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.